Skip to main content
SpringerLink
Log in

Lanthanum Carbonate

A Viewpoint by Mahmoud Loghman-Adham

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998 Apr; 31(4): 607–17

    Article  PubMed  CAS  Google Scholar 

  2. Ribeiro S, Ramos A, Brandao A, et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant 1998 Aug; 13(8): 2037–40

    Article  PubMed  CAS  Google Scholar 

  3. Graff L, Burnel D. A possible non-aluminum oral phosphate binder? A comparative study on dietary phosphorus absorption. Res Commun Mol Pathol Pharmacol 1995 Sep; 89(3): 373–88

    PubMed  CAS  Google Scholar 

  4. Altair Nanomaterials, Inc. RenaZorb™ [online]. Available from URL: http://altairnano.com/ [Accessed 2004 Jan 17]

Download references

Author information

Authors and Affiliations

  1. Basking Ridge, New Jersey, USA

    Mahmoud Loghman-Adham

Authors
  1. Mahmoud Loghman-Adham
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loghman-Adham, M. Lanthanum Carbonate. Drugs 64, 997–998 (2004). https://doi.org/10.2165/00003495-200464090-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200464090-00010

Search

Navigation